UNC Research Contributes to FDA Approval of New Drug for Rare Genetic Disorder
April 7, 2026
A clinical trial at UNC led by Joseph Muenzer, MD, PhD, paves the way for a first-of-its-kind treatment that can slow the progression of Hunter syndrome. A drug tested in a clinical trial at UNC, led by renowned UNC pediatric biochemical geneticist Joseph Muenzer, MD, PhD, has been approved by...